Travere Therapeutics. Every tracked FinTwit mention of $TVTX, newest first. 2 mentions since the first on Apr 13, 2026. See the price chart.
April 2026 · 2 mentions
Apr 16
Adam Feuerstein ✡️ — This week's Biotech Scorecard newsletter: $TVTX
Travere Therapeutics' drug for a rare kidney disease doesn’t improve kidney function. The FDA approved it anyway.
https://t.co/63h…↗